What dose of stereotactic body radiation therapy (SBRT) should be used for a peripheral 1.8‑cm lung lesion?

SBRT Dose for 1.8 cm Peripheral Lung Lesion

For a peripheral 1.8 cm lung lesion, the recommended SBRT dose is 48 Gy in 4 fractions or 54-60 Gy in 3 fractions, with the 3-fraction regimen providing superior local control at the cost of slightly increased toxicity.

Primary Dose Recommendations

The evidence strongly supports two main fractionation schemes for peripheral lesions of this size:

Three-Fraction Regimen (Preferred for Local Control)

• 54-60 Gy in 3 fractions delivers a biologically effective dose (BED) >100 Gy 1, 2
• This achieves 92% local control at 1 year and 89% at 4 years 3
• The ESTRO ACROP consensus specifically recommends 3×15 Gy (45 Gy total) for peripherally located lesions, with consideration of 3×18 Gy (54 Gy total) for patients free from severe comorbidities with favorable long-term survival expectancy 2
• Higher dose regimens (54-60 Gy/3 fractions) show only 4.3% local failure at 2 years compared to other fractionation schemes 4

Four-Fraction Regimen (Alternative with Lower Toxicity)

• 48 Gy in 4 fractions is the most commonly used regimen in Japan and widely validated 5
• For tumors 1.5-3.0 cm (which includes your 1.8 cm lesion), this delivers adequate BED with 86% local control at 3 years for tumors ≤3 cm 5
• Associated with lower chest wall toxicity (7.7%) compared to 3-fraction regimens (23.7%) 4

Algorithmic Decision Framework

Choose 54-60 Gy in 3 fractions if:

• Patient has good performance status (ECOG 0-1)
• No severe COPD or interstitial lung disease
• Tumor is truly peripheral (>2 cm from central structures)
• Goal is maximum local control
• Patient can tolerate slightly higher toxicity risk

Choose 48 Gy in 4 fractions if:

• Patient has significant comorbidities
• Concern for chest wall toxicity (tumor near ribs/pleura)
• Elderly patients with limited pulmonary reserve
• Preference for more conservative approach

Critical Technical Considerations

Prescription Parameters

• Prescribe to the encompassing isodose (typically 60-80% isodose line) 1, 2
• Maximum dose should be <125% to <150% of prescription dose 2
• PTV coverage: D95-D99 should receive prescription dose 2

Interfraction Timing

• For 4-fraction regimens, maintain ≥3 days between fractions to allow reoxygenation 5
• This is radiobiologically superior to consecutive daily treatments

Dose Constraints for Peripheral Lesions

• Chest wall: <30 Gy to <30 mL volume 6
• Ribs: Limit 2 mL volume to <27 Gy (3 fractions of 9 Gy) to keep rib fracture risk ~5% 6
• Lung: Mean lung dose as low as possible, preferably <8.5 Gy 7

Expected Outcomes

With appropriate dosing for a 1.8 cm peripheral lesion:

• Local control: 86-92% at 3 years 8, 5
• Overall survival: 69% at 3 years, 52% at 5 years for medically inoperable patients 5
• Grade ≥2 radiation pneumonitis: 10-13% 5
• Chest wall toxicity: 8-24% depending on fractionation 4

Common Pitfalls to Avoid

1. Underdosing: Regimens delivering BED <100 Gy show significantly worse local control (21% failure at 2 years with 30-34 Gy single fraction) 4

2. Ignoring lung density effects: Low-density lung tissue requires substantially higher monitor units and results in greater dose spillage despite acceptable conformity 9

3. Inadequate interfraction intervals: Daily fractions in 4-fraction regimens compromise reoxygenation benefits 5

4. Central lesion misclassification: If the lesion is actually within 2 cm of central structures, switch to 50 Gy in 5 fractions or 60 Gy in 8 fractions 3, 4

The evidence consistently demonstrates that for a 1.8 cm peripheral lung lesion, both 48 Gy/4 fractions and 54-60 Gy/3 fractions are effective, with the choice driven by patient factors and institutional preference for balancing local control against toxicity risk.